ライフサイエンスコーパス: glycopeptide antibiotic

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 tential role of each residue of this complex glycopeptide antibiotic.

2 is highly reproducible and selective toward glycopeptide antibiotics.

3 larization based method for the detection of glycopeptide antibiotics.

4 activities, and probably the structures, of glycopeptide antibiotics.

5 to desolvation of the ligand binding site in glycopeptide antibiotics.

6 the vancomycin and the teicoplanin class of glycopeptide antibiotics.

7 omycin, a member of the vancomycin family of glycopeptide antibiotics.

8 rinsic resistance to the vancomycin class of glycopeptide antibiotics.

9 Glycopeptide antibiotics are widely used in the treatmen

10 ichia coli, which is never challenged by the glycopeptide antibiotics because they cannot penetrate t

11 All the inducers identified were glycopeptide antibiotics, but teicoplanin, a membrane-an

12 -Ala cell wall precursor to d-Ala-d-Lac upon glycopeptide antibiotic challenge, displaying a potency

13 Bleomycin (BLM), a glycopeptide antibiotic chemotherapy agent, is capable o

14 ible for biosynthesis of the vancomycin-type glycopeptide antibiotic chloroeremomycin was recently se

15 es seen in three other crystal structures of glycopeptide antibiotics complexed with peptide ligands.

16 Like certain glycopeptide antibiotics (e.g., vancomycin), PGRPs kill

17 The adamantyl-2 amide of glycopeptide antibiotic eremomycin (1a in Chart 1, AN090

18 Glycopeptide antibiotics (GPAs) are nonribosomal peptide

19 Although glycopeptide antibiotics (GPAs), including vancomycin an

20 Chloroeremomycin, a vancomycin family glycopeptide antibiotic has three sugars, one D-glucose

21 The vancomycin family of glycopeptide antibiotics has been inspiring research in

22 Glycopeptide antibiotics have long served as drugs of la

23 In glycopeptide antibiotics, however, these cooperative pro

24 VanA-type resistance to glycopeptide antibiotics in clinical enterococci is regu

25 ence of resistance to vancomycin and related glycopeptide antibiotics is spurring efforts to develop

26 e bleomycins (BLMs) are structurally related glycopeptide antibiotics isolated from Streptomyces vert

27 to protoplasts that were pretreated with the glycopeptide antibiotic phleomycin, a nonspecific DNA do

28 In the glycopeptide antibiotic producers Streptomyces toyocaens

29 Second-generation glycopeptide antibiotics similar to vancomycin are in cl

30 ramoplanin is structurally less complex than glycopeptide antibiotics such as vancomycin, peptidomime

31 distinct hydroxyl groups within the complex glycopeptide antibiotic teicoplanin A2-2.

32 quantitate the binding affinity between the glycopeptide antibiotics teicoplanin from Actinoplanes t

33 results suggest new strategies for designing glycopeptide antibiotics that overcome bacterial resista

34 e essential to understanding the activity of glycopeptide antibiotics, the recognition of pathogens b

35 ed total syntheses of vancomycin and related glycopeptide antibiotics, their agylcons, and key analog

36 internuclear distances from the 19F of this glycopeptide antibiotic to natural-abundance 31P and to

37 nked the Lys-D-Ala-D-Ala binding epitope for glycopeptide antibiotics to three different carrier prot

38 Vancomycin is a glycopeptide antibiotic used for the treatment of Gram-p

39 The sugar residues of the glycopeptide antibiotic vancomycin contribute to the coo

40 ly established dimerization of the important glycopeptide antibiotic vancomycin in four different aqu

41 sors in bacteria, which are resistant to the glycopeptide antibiotic vancomycin.

42 dipeptidase essential for resistance to the glycopeptide antibiotic vancomycin.

43 The structurally related glycopeptide antibiotics vancomycin, ristocetin A, and t

44 Using three glycopeptide antibiotics, vancomycin, teicoplanin, and t

45 Oritavancin is a novel glycopeptide antibiotic with concentration-dependent kil

46 al component of the mannopeptimycins, cyclic glycopeptide antibiotics with activity against drug-resi

47 ycin, and we show that the activity of other glycopeptide antibiotics with this feature can also be s

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。